Novartis Home

Two female scientists, wearing masks, conducting innovative research experiments in R&D lab

At Novartis, we are reimagining medicine

Why healthcare's digital moment is now

Bertrand Bodson, Novartis CDO hosted a fireside chat with Microsft Exec Peter Lee to explore their health moonshots, COVID response and more.

Learn More

Novartis at ASH

Find the latest resources about Novartis data featured at the American Society of Hematology (ASH) Annual Meeting & Exposition.

Read More

Join the Co-Creating Impact Summit 2020

Novartis is hosting the Co-Creating Impact Summit on December 9th, 2020, gathering experts inside and outside of the company to discuss some key ESG topics.


Novartis included in Dow Jones Sustainability Index

Novartis is proud to be included in one of the most important ESG ratings.

Read More

Going 100% renewable in Europe

Novartis signs agreements expected to add more than 275 megawatts of clean power to the electrical grid.

Read More

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.


Our people, our stories, our culture on @novartislife Instagram

Find out more about our Inspired, Curious and Unbossed culture as we celebrate our people who are reimagining medicine and their stories on our new community channel @novartislife.

Learn More

Cell & Gene Therapy Explained

What if medicine for certain diseases only needed to be taken once?

Learn More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

Learn More

Our commitment to doing what's right

Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.

Learn More